Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-067838

Chief Operating Officer bought 10,000 shares at $1.42 ($14,200)

From the SEC's structured data for this filing

Trades in this filing

Dagnon Terry · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-03 Purchase : show line 1 in the form +10,000 $1.42 $14,200 1,137,857 D
Open-market purchases · 10,000 sh · avg $1.42 · $14,200
Loading xslF345X03/doc4.xml…